FGFR2-AHCYL1/BaF3
CBP73267
詢(xún) 價(jià)
留 言
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| I. Introduction | |
|
Cell Line Name： |
FGFR2-AHCYL1/BaF3 |
|
Host Cell: |
Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
|
Application: |
Anti-proliferation assay and PD assay |
|
Freeze Medium: |
90% FBS+10% DMSO |
|
Complete Culture Medium: |
RPMI-1640+10%FBS+2ug/ml puromycin |
|
Mycoplasma Status: |
Negative |
| II. Background | |
|
FGFR2-AHCYL1 results from the fusion of FGFR2 and AHCYL1, resulting in the ability to activate MAPK signaling and induce transformation of cells in culture and in animal models (PMID: 24122810). FGFR2-AHCYL1 has been identified in intrahepatic cholangiocarcinoma (PMID: 24122810). |
|
| III. Representative Data | |
|
1. WB of FGFR2-AHCYL1/BaF3
|
|
|
2. Sanger of FGFR2-AHCYL1/BaF3
|
|
|
3. Anti-proliferation assay
Figure 3. CTG Proliferation Assay of BaF3 FGFR2-AHCYL1 Cells(C1). |
|
|
|
|
